Literature DB >> 36108743

A STUB1 ubiquitin ligase/CHIC2 protein complex negatively regulates the IL-3, IL-5, and GM-CSF cytokine receptor common β chain (CSF2RB) protein stability.

Sebastian H J Koochaki1, Mikołaj Słabicki2, Ryan Lumpkin3, Charles Zou4, Roger Belizaire4, Eric S Fischer5, Benjamin L Ebert6.   

Abstract

The IL-3, IL-5, and GM-CSF family of cytokines plays an essential role in the growth, differentiation, and effector functions of multiple hematopoietic cell types. Receptors in this family are composed of cytokine-specific α chains and a common β chain (CSF2RB), responsible for the majority of downstream signaling. CSF2RB abundance and stability influence the magnitude of the cellular response to cytokine stimulation, but the exact mechanisms of regulation are not well understood. Here, we use genetic screens in multiple cellular contexts and cytokine conditions to identify STUB1, an E3 ubiquitin ligase, and CHIC2 as regulators of CSF2RB ubiquitination and protein stability. We demonstrate that Stub1 and Chic2 form a complex that binds Csf2rb, and that genetic inactivation of either Stub1 or Chic2 leads to reduced ubiquitination of Csf2rb. The effects of Stub1 and Chic2 on Csf2rb were greatest at reduced cytokine concentrations, suggesting that Stub1/Chic2-mediated regulation of Csf2rb is a mechanism of reducing cell-surface accumulation when cytokine levels are low. Our study uncovers a mechanism of CSF2RB regulation through ubiquitination and lysosomal degradation and describes a role for CHIC2 in the regulation of a cytokine receptor.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CHIC2; CSF2RB; E3 ubiquitin ligase; GM-CSF; IL-3; IL-5; STUB1; cell-surface receptor; cytokine; cytokine signaling; protein degradation; protein stability; receptor; signaling; ubiquitin; ubiquitin ligase

Year:  2022        PMID: 36108743      PMCID: PMC9574515          DOI: 10.1016/j.jbc.2022.102484

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.486


  37 in total

1.  Proteasomal regulation of betac signaling reveals a novel mechanism for cytokine receptor heterotypic desensitization.

Authors:  M Martinez-Moczygemba; D P Huston
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

2.  Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells.

Authors:  F Lanza; B Castagnari; G Rigolin; S Moretti; A Latorraca; L Ferrari; A Bardi; G Castoldi
Journal:  Leukemia       Date:  1997-10       Impact factor: 11.528

3.  Interleukin-3, GM-CSF, and G-CSF receptor expression on cell lines and primary leukemia cells: receptor heterogeneity and relationship to growth factor responsiveness.

Authors:  L S Park; P E Waldron; D Friend; H M Sassenfeld; V Price; D Anderson; D Cosman; R G Andrews; I D Bernstein; D L Urdal
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

4.  Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras.

Authors:  Tim Wang; Haiyan Yu; Nicholas W Hughes; Bingxu Liu; Arek Kendirli; Klara Klein; Walter W Chen; Eric S Lander; David M Sabatini
Journal:  Cell       Date:  2017-02-02       Impact factor: 41.582

Review 5.  The βc receptor family - Structural insights and their functional implications.

Authors:  Sophie E Broughton; Tracy L Nero; Urmi Dhagat; Winnie L Kan; Timothy R Hercus; Denis Tvorogov; Angel F Lopez; Michael W Parker
Journal:  Cytokine       Date:  2015-05-14       Impact factor: 3.861

6.  Interleukin-3 and granulocyte-monocyte colony-stimulating factor receptors on human acute myelocytic leukemia cells and relationship to the proliferative response.

Authors:  L M Budel; I P Touw; R Delwel; S C Clark; B Löwenberg
Journal:  Blood       Date:  1989-08-01       Impact factor: 22.113

7.  Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.

Authors:  Masashi Sanada; Takahiro Suzuki; Lee-Yung Shih; Makoto Otsu; Motohiro Kato; Satoshi Yamazaki; Azusa Tamura; Hiroaki Honda; Mamiko Sakata-Yanagimoto; Keiki Kumano; Hideaki Oda; Tetsuya Yamagata; Junko Takita; Noriko Gotoh; Kumi Nakazaki; Norihiko Kawamata; Masafumi Onodera; Masaharu Nobuyoshi; Yasuhide Hayashi; Hiroshi Harada; Mineo Kurokawa; Shigeru Chiba; Hiraku Mori; Keiya Ozawa; Mitsuhiro Omine; Hisamaru Hirai; Hiromitsu Nakauchi; H Phillip Koeffler; Seishi Ogawa
Journal:  Nature       Date:  2009-07-20       Impact factor: 49.962

8.  A subcellular map of the human proteome.

Authors:  Peter J Thul; Lovisa Åkesson; Mikaela Wiking; Diana Mahdessian; Aikaterini Geladaki; Hammou Ait Blal; Tove Alm; Anna Asplund; Lars Björk; Lisa M Breckels; Anna Bäckström; Frida Danielsson; Linn Fagerberg; Jenny Fall; Laurent Gatto; Christian Gnann; Sophia Hober; Martin Hjelmare; Fredric Johansson; Sunjae Lee; Cecilia Lindskog; Jan Mulder; Claire M Mulvey; Peter Nilsson; Per Oksvold; Johan Rockberg; Rutger Schutten; Jochen M Schwenk; Åsa Sivertsson; Evelina Sjöstedt; Marie Skogs; Charlotte Stadler; Devin P Sullivan; Hanna Tegel; Casper Winsnes; Cheng Zhang; Martin Zwahlen; Adil Mardinoglu; Fredrik Pontén; Kalle von Feilitzen; Kathryn S Lilley; Mathias Uhlén; Emma Lundberg
Journal:  Science       Date:  2017-05-11       Impact factor: 47.728

9.  The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K.

Authors:  Mikołaj Słabicki; Zuzanna Kozicka; Georg Petzold; Yen-Der Li; Manisha Manojkumar; Richard D Bunker; Katherine A Donovan; Quinlan L Sievers; Jonas Koeppel; Dakota Suchyta; Adam S Sperling; Emma C Fink; Jessica A Gasser; Li R Wang; Steven M Corsello; Rob S Sellar; Max Jan; Dennis Gillingham; Claudia Scholl; Stefan Fröhling; Todd R Golub; Eric S Fischer; Nicolas H Thomä; Benjamin L Ebert
Journal:  Nature       Date:  2020-06-03       Impact factor: 49.962

10.  Discovery and functional characterization of a germline, CSF2RB-activating mutation in leukemia.

Authors:  K Watanabe-Smith; C Tognon; J W Tyner; J P P Meijerink; B J Druker; A Agarwal
Journal:  Leukemia       Date:  2016-04-27       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.